Charles Schwab Investment Management »

Eliem Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Eliem Therapeutics (ELYM) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $357k 70k 5.09
2024-06-30 $122k 17k 7.11
2022-03-31 $135k 16k 8.44
2021-12-31 $181k 17k 10.51
2021-09-30 $310k 17k 18.00